Beverley Carr

Beverley Carr is an accomplished business leader with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Chief Business Officer at CHARM Therapeutics since August 2024, Carr has previously held significant roles including Interim Chief Executive Officer and Chief Business and Operating Officer at Amphista Therapeutics Limited, and Chief Business Officer at Achilles Therapeutics Limited. Prior positions include a range of leadership roles at GSK, where Carr was VP of Business Development in Immunoinflammation and dermatology, along with entrepreneurial experiences at various companies. Educational qualifications encompass an MBA from the University of Cambridge and a D Phil in Organic Chemistry, as well as an MA in Chemistry from the University of Oxford.